C60 (Fullerene): The Definitive Guide

What is C60?

C60, or buckminsterfullerene, is a hollow carbon molecule made from 60 atoms arranged in a cage. It is a manufactured nanomaterial, not an essential nutrient. There is no RDA, adequate intake, tolerable upper intake level or recognized C60 deficiency.

Online products commonly dissolve C60 in oil. That finished exposure is not interchangeable with water-dispersed C60, hydroxylated fullerene, a C60/C70 mixture or a drug-delivery fullerene derivative. Purity, aggregation, carrier oil and light exposure can change what is in the bottle and how it behaves. [2], [5], [7]

Interest in oral C60 comes mainly from a 2012 rat study that reported a striking lifespan result. The paper later received a corrigendum for errors in Figures 3 and 4. Subsequent mouse work did not reproduce extension beyond untreated or water controls. No controlled oral human study closes that gap. [1]–[3]

Typical C60 Protocols

These rows do not form a dose ladder. The Baati lifespan schedule was intermittent, the Burres study was a 14-day toxicity test whose methods call 5 mL/kg of 0.8 mg/mL solution both 4 mg/kg and 3.8 mg/kg, and the Moussa study tested a C60/C70 mixture over two administrations. Converting any animal amount by body weight or surface area would create human instructions unsupported by pharmacokinetic or clinical evidence.

Material identity

Record C60 versus C60/C70, derivative, stated purity, concentration, carrier oil and lot; they are not interchangeable.

Light history

Record packaging, storage and suspected exposure. Dark storage addresses one hazard and does not establish overall safety.

Evidence type

Keep lifespan, acute toxicity, genotoxicity and mechanism results in separate fields; each answers a different question.

What is C60 commonly used for?

Longevity

The longevity claim rests on animal experiments, not human outcomes. Baati et al. reported that repeated oral C60-oil almost doubled rat lifespan. Later C57BL/6J work found no lifespan or healthspan benefit versus untreated controls. In CBA/Ca mice, C60 animals outlived olive-oil controls but lived about as long as water controls, suggesting a carrier comparison rather than extension beyond baseline. [1]–[3]

Species, strain, carrier, preparation, storage and study design differ. Those differences may help explain disagreement, but they do not rescue a human claim. There is no evidence that C60 extends human life or slows a validated human aging outcome.

Antioxidant and mitochondrial claims

C60 can participate in redox chemistry, and a 2013 paper proposed proton uptake and mild mitochondrial uncoupling as an antioxidant mechanism. The argument depends mainly on modelling and preclinical evidence. C60 can also sensitize singlet oxygen under light. Calling it simply an “antioxidant” hides this context-dependent chemistry. [6], [7]

Other disease claims

Cell, animal and drug-delivery studies investigate fullerene materials in many settings. They use chemically distinct derivatives, routes and formulations. They do not show that an oral consumer C60-oil product treats cancer, neurodegeneration, inflammation, infection or exercise recovery.

How do forms and labels differ?

A label may say C60, buckminsterfullerene, carbon 60, fullerene oil, C60/C70 or fullerenol. These terms do not identify the same material. Carrier oil and concentration describe only part of the finished product; impurity profile, particle state, preparation and light history may also matter.

Grohn et al. found marked discrepancies among online C60-oil samples compared with laboratory-prepared material. A seller certificate does not prove that the opened bottle retains the tested identity, concentration or photochemical state. [2]

How should C60 products be stored?

The safest evidence-led conclusion is not a home storage protocol. Light exposure changed C60-oil chemistry and toxicity in mice, so a product with uncertain packaging, storage or exposure history should not be treated as verified material. Dark storage cannot undo prior exposure and does not solve impurities, aggregation or the absence of human safety data.

Do not rely on an invented universal shelf life. Keep the original label and lot information for clinical or poison-control review, and follow local hazardous-product disposal advice rather than transferring the liquid to an unlabelled container.

What does the human evidence show?

The evidence is preclinical and internally inconsistent on the headline outcome. The best later data add a specific photochemical hazard and narrow short-term safety results. They do not produce a human benefit-risk estimate. [1]–[7]

What are the risks and interactions?

The main known concerns are absence of human safety data, light-dependent toxic products in an animal model, inconsistent commercial material, possible impurities and uncertain effects of chronic exposure. A person with vomiting, severe abdominal pain, weakness, confusion, breathing trouble, fainting or another acute change after use needs urgent assessment; bring the product container when possible.

There are no reliable human interaction studies. That means “no interactions found” would be misleading. Pregnancy, breastfeeding, childhood use, kidney or liver disease, cancer therapy, planned surgery and any complex medication regimen require clinician review. A theoretical antioxidant interaction should not be used to predict safety with chemotherapy or other treatment.

What is the legal and regulatory status?

C60 is an experimental nanomaterial rather than an established nutrient. In 2020, FDA warned a named seller that C60 products promoted with COVID-19 treatment or prevention claims were unapproved and misbranded drugs. That enforcement action addresses disease claims and does not amount to approval of ordinary oral C60 use. [8]

In Canada, an authorized natural health product should carry an NPN or DIN-HM that can be checked in Health Canada’s database. A product appearing online or using the word “supplement” does not prove authorization. The European SCCS concluded that available information was insufficient to establish safety for specified cosmetic fullerene nanomaterials; that cosmetic opinion is not an oral approval. [9], [10]

What happens when you stop?

No human study defines withdrawal, persistence or elimination after repeated oral C60-oil use. There is no evidence-based taper. Do not assume that new symptoms are “detox.” Record the last exposure, product and timing, and seek clinical or poison-control advice for concerning symptoms.

What should you monitor?

If exposure has already occurred, record the exact product, lot, fullerene form, carrier oil, labelled concentration, amount, time, storage and light history, medicines, other supplements and new symptoms. Preserve photos of the label and container.

There is no validated consumer blood test, oxidative-stress score or wearable metric that proves benefit or safety. Routine labs may help a clinician assess symptoms, but they do not certify the product or measure longevity.

What does community experience add?

Public reports can reveal label confusion, carrier-oil complaints and inconsistent storage practices. They cannot verify purity, light degradation, systemic exposure, lifespan benefit or a safe dose. No systematic current community sample was assembled, so this guide reports no consensus protocol, brand ranking or responder rate.

How does C60 compare with related options?

Common questions

Has C60 been tested in humans?

No controlled oral human trial establishes longevity benefit, a safe dose, pharmacokinetics or long-term safety. Human work with a topical fullerene formulation or another derivative does not validate oral C60-oil.

Did C60 double rat lifespan?

One 2012 study reported an almost doubled lifespan. A corrigendum later corrected errors in two figures, and later mouse studies did not reproduce extension beyond untreated or water controls. [1]–[3]

Does storing C60 in the dark make it safe?

It addresses one observed light-dependent hazard. It does not prove purity, prevent all degradation, establish chronic safety or replace missing human trials.

Is C60 an antioxidant?

Its redox behaviour depends on formulation and conditions. It can scavenge radicals in some systems and sensitize reactive singlet oxygen under light in others. A one-word label is incomplete. [6], [7]

What human dose was used in trials?

None. No validated oral human protocol exists, and animal doses should not be converted into consumer instructions.

Do negative toxicity tests prove safety?

No. The 14-day rat test and two-dose mouse micronucleus test answer narrow questions over short periods. They do not establish long-term human safety. [4], [5]

Is C60 approved as a longevity treatment?

No. Disease or longevity marketing does not make a product an approved treatment. Verify the finished product and jurisdiction rather than inferring status from a seller’s label.

Glossary

Plain explanations of C60 research terms.

Fullerene

A cage-like carbon molecule; C60 contains 60 carbon atoms.

Nanomaterial

Material with structural features on the nanoscale, where preparation and particle properties can influence behaviour.

Photooxidation

Light-driven chemical change involving oxygen that can create different reaction products.

Healthspan

Time lived with preserved health or function, distinct from lifespan.

Micronucleus test

A genotoxicity assay that looks for chromosome damage or chromosome-loss signals in cells.

Corrigendum

A published correction to an article; it must be reviewed when interpreting the original report.

How this guide was researched

Primary PubMed identities, full reports where available, the Baati corrigendum and official regulatory pages were checked. Animal species, formulation, route, schedule, comparator and endpoint were extracted separately. No animal-to-human dose conversion was performed.

Explore the sources

Related guides

• Urolithin A
• Spermidine
• NAD+ precursors
• CoQ10
• Longevity and cellular health

Editorial note

This guide keeps carbon chemistry, product identity, animal lifespan findings, short safety assays and human clinical outcomes separate. It does not turn preclinical schedules into consumer instructions.